Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
31 May 2020	Submitted	Original manuscript
7 Jun 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
7 Jun 2020	Editorially accepted
19 Jun 2020	Article published	10.1186/s13063-020-04488-8

Back to article page